Close
4

Seqens Seqens

X

Company profile for Anokion SA

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Anokion SA (including our wholly-owned subsidiaries Anokion US, Inc. and Kanyos Bio, Inc.) is focused on improving the treatment and outcomes of autoimmune disease. Our proprietary antigen-specific immune tolerance technology is designed to be both more effective and specific than the current standard of care. Patients suffering from autoimmune diseases harbor immune cells that mistakenly recognize and attack the body’s o...
Anokion SA (including our wholly-owned subsidiaries Anokion US, Inc. and Kanyos Bio, Inc.) is focused on improving the treatment and outcomes of autoimmune disease. Our proprietary antigen-specific immune tolerance technology is designed to be both more effective and specific than the current standard of care. Patients suffering from autoimmune diseases harbor immune cells that mistakenly recognize and attack the body’s own cells (self-proteins) as foreign entities. This can lead to tissue destruction, inflammation, and any number of serious complications. The cells that cause these erroneous attacks are known as autoreactive cells.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Anokion SA
Switzerland Flag
Country
Country
Switzerland
Address
Address
EPFL Innovation Park-L Chemin de la Dent d’Oche 1A CH-1024 Ecublens
Telephone
Telephone
+1 857.320.6607
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY